Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Dyspnea × Fentanyl × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 14 Neoplasms 6 Colonic Neoplasms 5 Agnosia 5 Lung Neoplasms 4 Head and Neck Neoplasms 4 Cancer Pain 4 Breast Neoplasms 4 Rectal Neoplasms 3 Prostatic Neoplasms 3 Pain, Postoperative 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 2 Pancreatic Neoplasms 2 Lymphoma, Follicular 2 Diverticulosis, Colonic 2 Chronic Pain 2 Breakthrough Pain 2 post laminectomy syndrome 1 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Thrombocythemia, Essential 1 Terminal Cancer 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1

Interventions

Surveys and Questionnaires 5 Dexamethasone 2 Calcium Dobesilate 2 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Tiotropium Bromide 1 Sugars 1 Standard of Care 1 Respiratory Therapy 1 Rehabilitation 1 Oxygen 1 Midazolam 1 Losartan 1 Lisinopril 1 Hypnosis 1 Hematologic Tests 1 Furosemide 1 Fentanyl 1 Exercise 1 Educational Status 1 Echocardiography 1 Dexmedetomidine 1 Buspirone 1 Behavior Therapy 1 Aromatherapy 1 Acupuncture Therapy 1 Acupressure 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01515566 2014-08-22

Breakthrough Dyspnea Fentanyl Study in Cancer Patients

M.D. Anderson Cancer Center

Phase 1/2 Completed

26 enrolled 7 charts

Dyspnea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡